Department of Dermatology, Lahey Hospital & Medical Center, Beth Israel Lahey System, Burlington, Massachusetts.
Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts.
Dermatol Surg. 2022 Jul 1;48(7):758-763. doi: 10.1097/DSS.0000000000003501.
The US FDA mandates that manufacturers and device operators disclose medical device reports (MDRs) to monitor suspected injuries and device malfunctions by submitting information to the Manufacturer and User Facility Device Experience (MAUDE) database. Given the rapid growth in the noninvasive fat and cellulite reduction market, it is essential that physicians be aware of associated adverse events.
STUDY DESIGN/MATERIALS AND METHODS: Using the MAUDE electronic database on the FDA website, the authors performed a comprehensive search of reported complications of noninvasive fat reduction and cellulite reduction devices from January 1, 2014 to January 1, 2020 at http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/search.cfm. Medical device reports that likely represented medical adverse events from device use were included.
The search yielded 165 MDRs, a majority submitted by patients. There were 68 MDRs reported on cryolipolysis (41.2%), 34 MDRs reported on 1,060-nm laser lipolysis (20.6%), 19 MDRs reported on high-intensity focused ultrasound (11.5%), 17 MDRs reported on vacuum-assisted subcision (10.3%), 10 MDRs reported on 1,440-nm laser-assisted subcision (6.1%), 8 MDRs reported on monopolar radiofrequency (4.8%), 6 MDRs reported on focused ultrasound (3.6%), and 4 MDRs reported for a combination infrared light, bipolar radiofrequency energy, massage, and gentle suction treatment (2.4%).
It can be safely presumed that most physicians do not regularly report adverse events to the FDA; however, the MAUDE database remains the largest global repository of adverse events reported for noninvasive body contouring devices, an area that has grown tremendously over the last few years. Some MDRs may be unrelated and/or unsubstantiated, and MDRs for any given device must be correlated to the total number of procedures performed. Nevertheless, the MAUDE database allows a glimpse into potential adverse events that can occur. The authors hope that physician awareness of this database and the adverse events it reports will help improve patient safety.
美国食品药品监督管理局(FDA)要求制造商和设备操作人员通过向制造商和用户设施设备体验(MAUDE)数据库提交信息,披露医疗器械报告(MDR)以监测疑似伤害和设备故障。鉴于非侵入性脂肪和 cellulite 减少市场的快速增长,医生必须了解相关的不良事件。
研究设计/材料和方法:作者使用 FDA 网站上的 MAUDE 电子数据库,从 2014 年 1 月 1 日至 2020 年 1 月 1 日,在 http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/search.cfm 上对非侵入性脂肪减少和 cellulite 减少设备的报告并发症进行了全面搜索。包括可能代表设备使用中出现的医疗不良事件的医疗器械报告。
搜索产生了 165 份 MDR,其中大多数是由患者提交的。68 份 MDR 报告涉及冷冻溶脂(41.2%),34 份 MDR 报告涉及 1060nm 激光脂肪溶解(20.6%),19 份 MDR 报告涉及高强度聚焦超声(11.5%),17 份 MDR 报告涉及真空辅助下切除(10.3%),10 份 MDR 报告涉及 1440nm 激光辅助切除(6.1%),8 份 MDR 报告涉及单极射频(4.8%),6 份 MDR 报告涉及聚焦超声(3.6%),4 份 MDR 报告涉及红外光、双极射频能量、按摩和轻柔抽吸治疗的组合(2.4%)。
可以合理地假设,大多数医生不会定期向 FDA 报告不良事件;然而,MAUDE 数据库仍然是全球最大的非侵入性身体轮廓设备不良事件报告库,在过去几年中,该领域增长迅速。一些 MDR 可能与设备无关,或者没有得到证实,并且必须将给定设备的 MDR 与执行的总例数相关联。尽管如此,MAUDE 数据库使人们对可能发生的不良事件有了一定的了解。作者希望医生对该数据库及其报告的不良事件的认识将有助于提高患者的安全性。